Venmax Drugs & Pharmaceuticals
VENMAXBSE

Venmax Drugs & Pharmaceuticals

₹25.180.98 (4.05%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
22.85
Today’s high
25.85
52 week low
19.01
52 week high
36.96
Open price
25.85
Previous close
24.20
Live volume
5,677
Lower circuit
19.36
Upper circuit
29.04

Fundamentals

Market Cap
₹28Cr
ROE
4.02%
P/E Ratio(TTM)
32.27
EPS(TTM)
0.75
P/B Ratio
1.78
Dividend Yield
0.00%
Industry P/E
43.03
Book Value
13.58
Debt to Equity
0.36
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹1.62
+22.73%
Profit (Cr)
₹0.03
+50.00%
-2-1012
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+710%
3Y CAGR-2%
Profit growthValue
1Y (TTM)+106%

About

Venmax is primarily engaged in the manufacturing and trading of pharmaceutical formulations, drug intermediates, and Active Pharmaceutical Ingredients (APIs). The company is currently developing oncology products and is in the planning stages of establishing a new manufacturing unit with a cGMP facility at the Hyderabad Pharma Cluster to target export markets.;
CEO/MD
Mr. Venkata Rao Sadhanala
Founded in
1988
BSE symbol
531015

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
86.20%
Promoters
13.80%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹874.90
+3.05 (0.35%)
L
    H
    4,968.5535.254.55
    ₹377.50
    +15.20 (4.20%)
    L
      H
      3,946.1882.4914.92
      ₹404.05
      +2.05 (0.51%)
      L
        H
        3,756.3841.915.15
        Orchid PharmaORCHPHARMA
        ₹695.55
        -13.10 (1.85%)
        L
          H
          3,589.90190.272.82
          2026
          14
          May
          Quarterly & Annual Result
          Upcoming
          Release date
          7
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks